Vaccine Therapy in Treating Patients With Stage IV Cutaneous Melanoma

NCT00074230 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: Autologous Dendritic Cells loaded with MAGE-A3, MelanA and Survivin

Sponsor

University Hospital Erlangen